By Marina Lopes NEW YORK (Reuters) - At the Henley Vaporium, one of a growing number of e-cigarette lounges sprouting up in New York and other U.S. cities, patrons can indulge in their choice of more than 90 flavors of nicotine-infused vapor, ranging from bacon to bubble gum. A sprawling sign on one wall lists all the carcinogens that e-cigarette users avoid by kicking their smoking habits and using the e-devices instead. The product, introduced in China in 2006, has become a worldwide trend at least in part because it may help smokers of regular cigarettes break the habit. "It's an addiction - not everyone can quit cold turkey," said Nick Edwards, 34, a Henley employee who says he kicked a 15-year cigarette habit the day he tried his first e-cigarette.
By David Lawder and Thomas Ferraro WASHINGTON (Reuters) - Republicans in the U.S. House of Representatives on Wednesday were falling in line behind a two-year budget deal negotiated behind closed doors, indicating that the normally rambunctious group of lawmakers is not spoiling for a year-end fiscal fight. Despite conservative groups denouncing the $85 billion plan, the Republican-controlled House could vote as early as Thursday to lock into place a measure that would minimize chances of any further government shutdowns at least until October 2015. Representative Tom Cole told reporters that a majority of his fellow House Republicans would vote for the budget deal, which would replace some of the indiscriminate, across-the-board agency spending cuts scheduled for the next two years. "A lot of support was expressed for it" during a closed meeting of House Republicans, Cole told reporters.
(Reuters) - CytRx Corp said its experimental cancer treatment improved survival rates in untreated soft tissue sarcoma patients without the disease progressing, compared with standard chemotherapy alone, sending the company's shares up as much as 83 percent. The mid-stage trial tested the therapy, aldoxorubicin, against chemotherapy drug, doxorubicin, in 123 patients every three weeks for up to six cycles. About 67 percent of patients who received aldoxorubicin showed no disease progression at six months compared with about 36 percent of patients treated with doxorubicin, according to investigators at study sites. Aldoxorubicin combines the chemotherapeutic agent, doxorubicin, with a linker-molecule that binds to albumin in the blood, allowing for the delivery of higher doses of doxorubicin.
Regular soft drinks and many fruit juice beverages and sports drinks are sweetened with added sugars such as sucrose or high fructose corn syrup, while 100-percent fruit juices only contain natural sugars. Milk has natural sugar too, even though it isn't sweet. Diet soft drinks may taste sweet, but they don't contain any sugar. "Some dietary recommendations call out 'sugary' beverages," lead researcher Gail Rampersaud told Reuters Health in an email.
Take a moment to think about the last time you memorized someone's phone number. And when was the last time you were at a dinner party or having a conversation with friends, when you whipped out your smartphone to Google the answer to someone's question?
Let's get into that sweet spot of really accepting and cherishing our vulnerabilities, our humanness and ourselves! Let's embrace the whole package, the things we are good at and the things we are not so good at, because that is how we find our confidence and how we make the ground we walk on not only steady, but sacred.
Agency hopes to limit antibiotic resistant diseases in humans by phasing out the use in animals. Â Â Â Â
WASHINGTON (AP) â Citing a potential threat to public health, the Food and Drug Administration moved Wednesday toward phasing out the use of some antibiotics in animals processed for meat.
WASHINGTON (AP) â Playing catch-up with a long way to go, President Barack Obama's new health insurance markets last month picked up the dismal pace of signups, the administration reported Wednesday.